The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
Horizon: Validation of an improved method for rapid characterization of protein aggregates in biologic drugs for increased quality and safetySBC: OPTOFLUIDICS, INC. Topic: NA
Optofluidics and the University of Delaware propose to complete the development of the Horizon technology and carry out validation via a comprehensive multi-site study. The technology is a subvisible particle analyzer pioneered during Phase I. The technology is designed to fill two critical gaps in biopharmaceutical product development: (1) Scientists can count and image particles with current too ...SBIR Phase II 2017 Department of CommerceNational Institute of Standards and Technology
SBC: Risk Management Systems Topic: N/A
THE RESEARCH PROGRAM WILL DEVELOP A MICROCOMPUTER BASED SYSTEM OF HARDWARE AND SOFTWARE WHICH WILL ALLOW THE USER TOEXECUTE MAINFRAME BASED CODES ON THE MICROCOMPUTER. IN ADDITION PARALLEL EXECUTION OF SEVERAL CODES AT ONCE IS POSSIBLEA SPECIAL INPUT AND OUTPUT PROCESSOR MODULES WILL ALSO BE DEVELOPED TO DEMONSTRATE THE USER FRIENDLY CAPABILITIES OF THE SYSTEM AND FACILITATE INPUT PREPARATION AND ...SBIR Phase II 1989 Nuclear Regulatory Commission
SBC: Technology International Incorporated of Virginia Topic: N/A
WORKER/DOSIMETER (W/D) GEOMETRY AND RELATIONSHIP TO A SOURCEOF RADIATION CAN PROVIDE FALSE RECORDING OF THE RADATION DOSE RECEIVED BY AN INDIVIDUAL. HENCE, TECHNOLOGY INTERNATIONAL INCORPORATED (TII) IS PROPOSING A TWO PHASE EFFORT WHICH INVOLVES A COMPUTER SIMULATION EXPERIMENT USING GEOMETRIC MODELING IN CONJUNCTION WITH A DOSE COMPUTATION ALGORITHM, FOLLOWED BY PERFORMANCE OF EXPERIMENTEMPLOYIN ...SBIR Phase I 1989 Nuclear Regulatory Commission